Sign in

NCT03156478Recruiting

STOP DIABETES - Knowledge-based Solutions

Source: ClinicalTrials.gov · Last updated 17 May 2017 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The aim of the Stop Diabetes - Knowledge based solutions (StopDia) consortium project (University of Eastern Finland, National Institute for Health and Welfare, and Technical Research Centre of Finland) is to develop and test approaches to identify individuals at increased risk of type 2 diabetes and to empower them in adopting and maintaining a healthy lifestyle by combining individual and environment level strategies into a dual-process approach targeting deliberative and automatic processes of behavior. We also aim to identify barriers and facilitators of adopting a healthy lifestyle in the society, create a model for the prevention of type 2 diabetes by joint actions of health care, third sector, and other societal actors, and develop methods to monitor the cost-effectiveness of these actions. We will carry out a 1-year randomized controlled trial on the effects of among 10 000 individuals aged 18-70 years at increased risk of type 2 diabetes living in Finland. The participants will be randomized into the control group, the digital lifestyle intervention group, or the combined digital and face-to-face lifestyle intervention group. The aim of the interventions is to enhance diet quality, increase physical activity, decrease body weight, and improve glucose tolerance in individuals at increased risk of type 2 diabetes.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
10000 (estimated)
First submitted
13 Apr 2017
Start date
10 Apr 2017
Primary completion date
31 Dec 2018
Lead sponsor
University of Eastern Finland
NCT number
NCT03156478

What you commit to

  • Study type: Interventional
  • Planned participants: 10000
  • From 10 Apr 2017 to the primary completion date, 31 Dec 2018
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • type 1 or 2 diabetes
  • current cancer or less than 6 months from the end of cancer treatment

Other

  • pregnancy or breastfeeding

Who the study is looking for

  • age of 18-70 years
  • 12 points or more in the Finnish diabetes risk score or previous gestational diabetes or repeated impaired fasting glucose (IFG) (fasting plasma glucose level 6,1 - 6,9 mmol/l) or impaired glucose tolerance (2-hour glucose level 7,8 - 11,0 mmol/l in oral glucose tolerance test)
  • living in the hospital district of Northern Savo, Päijät-Häme or South Karelia
  • possibility to use computer, smartphone or tablet with internet connection
  • having own self-phone number
  • adequate Finnish language skill

Age in the registry: 18 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University Of Eastern Finland
Coordinator of this site? Confirm its status
KuopioFinlandRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.